These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23233113)

  • 1. Serum IGF1, metabolic syndrome, and incident cardiovascular disease in older people: a population-based study.
    van Bunderen CC; Oosterwerff MM; van Schoor NM; Deeg DJ; Lips P; Drent ML
    Eur J Endocrinol; 2013 Mar; 168(3):393-401. PubMed ID: 23233113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study.
    van Bunderen CC; van Nieuwpoort IC; van Schoor NM; Deeg DJ; Lips P; Drent ML
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4616-24. PubMed ID: 20610588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF1 and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men.
    Yeap BB; Chubb SA; Ho KK; Setoh JW; McCaul KA; Norman PE; Jamrozik K; Flicker L
    Eur J Endocrinol; 2010 Feb; 162(2):249-57. PubMed ID: 19917654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma osteocalcin levels as a predictor of cardiovascular disease in older men and women: a population-based cohort study.
    Holvik K; van Schoor NM; Eekhoff EM; den Heijer M; Deeg DJ; Lips P; de Jongh R
    Eur J Endocrinol; 2014 Aug; 171(2):161-70. PubMed ID: 24801588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
    J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population.
    Olynyk JK; Knuiman MW; Divitini ML; Davis TM; Beilby J; Hung J
    Am J Gastroenterol; 2009 Jul; 104(7):1715-22. PubMed ID: 19491832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of IGF1 and IGFBPs 1 and 3 with all-cause and cardiovascular mortality in older men: the Health In Men Study.
    Yeap BB; Chubb SA; McCaul KA; Ho KK; Hankey GJ; Norman PE; Flicker L
    Eur J Endocrinol; 2011 May; 164(5):715-23. PubMed ID: 21378090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteocalcin as a predictor of the metabolic syndrome in older persons: a population-based study.
    Oosterwerff MM; van Schoor NM; Lips P; Eekhoff EM
    Clin Endocrinol (Oxf); 2013 Feb; 78(2):242-7. PubMed ID: 22435398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam.
    Schalk BW; Visser M; Bremmer MA; Penninx BW; Bouter LM; Deeg DJ
    Am J Epidemiol; 2006 Nov; 164(10):969-77. PubMed ID: 16980573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid function and the metabolic syndrome in older persons: a population-based study.
    Heima NE; Eekhoff EM; Oosterwerff MM; Lips PT; van Schoor NM; Simsek S
    Eur J Endocrinol; 2013 Jan; 168(1):59-65. PubMed ID: 23093697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of vitamin D status to risk of cardiovascular disease and mortality.
    Skaaby T
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population.
    Andreassen M; Raymond I; Kistorp C; Hildebrandt P; Faber J; Kristensen LØ
    Eur J Endocrinol; 2009 Jan; 160(1):25-31. PubMed ID: 18931092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional and longitudinal associations between insulin-like growth factor I and metabolic syndrome: a general population study in German adults.
    Friedrich N; Nauck M; Schipf S; Völzke H; Brabant G; Wallaschofski H
    Diabetes Metab Res Rev; 2013 Sep; 29(6):452-62. PubMed ID: 23576494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different types of alcoholic beverages and incidence of metabolic syndrome and its components in a Mediterranean cohort.
    Barrio-Lopez MT; Bes-Rastrollo M; Sayon-Orea C; Garcia-Lopez M; Fernandez-Montero A; Gea A; Martinez-Gonzalez MA
    Clin Nutr; 2013 Oct; 32(5):797-804. PubMed ID: 23305606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.